It is our mission to develop better treatments for the current Covid-19 pandemic, and to ensure that we are prepared for future viral pandemics @thechandalab
In a new @nchembio study, @chrisgparker and @Teijaro_Lab have developed an inhibitor for SLC15A4, a protein that was largely considered 'undruggable', offering hope against autoimmune diseases such as lupus and Crohn’s.
Read the full press release below: https://t.co/8MYpDfryna
Now we're talking!
A trivalent nasal vaccine vs mumps, measles and Covid, broadly effective vs #SARSCoV2 variants, with expected long duration (using preS-6P), in multiple experimental models https://t.co/04Iy13n552
@PNASNews
Good to see
FDA authorizes Novavax's updated COVID vaccine for fall 2023 - CBS News
Now the question is how long it would take to be accessible https://t.co/gmPuGio7D9
#NIAfunded research suggests that loss of taste may be caused by persistent damage to taste buds by low levels of the #COVID19 virus, which can linger for months or even longer than a year. Learn more about the #research study: https://t.co/ScQoGDwEL4
Scripps Research scientists @flaneuseks @andrewsu@chunleiwu have partnered with @NIAIDBioIT to launch the NIAID Data Ecosystem Discovery Portal - a searchable interface of infectious & immune-mediated datasets
The Scripps Research community mourns the passing of Michael Oldstone, MD, esteemed virologist and professor emeritus, who helped establish the viral pathogenesis field and shaped our understanding of host immune responses https://t.co/v21IUqSVii
Scientists in @WardLab1 have determined the structure of the critical protein complex that lets #Lassa virus infect human cells. They also identify new antibodies that bind & neutralize the virus, paving the way toward more effective vaccines & treatments https://t.co/Bb5DrvHpjH